Endovascular Interventions for Peripheral Artery Disease: A Contemporary Review

Curr Cardiol Rep. 2023 Nov;25(11):1611-1622. doi: 10.1007/s11886-023-01973-9. Epub 2023 Oct 7.

Abstract

Purpose of review: Peripheral artery disease (PAD) is an increasingly prevalent but frequently underdiagnosed condition that can be associated with high rates of morbidity and mortality. While an initial noninvasive approach is the cornerstone of management, revascularization is often pursued for patients with treatment-refractory claudication or chronic limb-threatening ischemia (CLTI). In this review, we discuss the current state of endovascular interventions for PAD and explore the many new emerging technologies.

Recent findings: The last decade has resulted in numerous advances in PAD interventions including the ongoing evolution of drug-coated devices, novel approaches to complex lesions, and contemporary evidence from large clinical trials for CLTI. Advances in endovascular management have allowed for increasingly complex lesions to be tackled percutaneously. Future directions for the field include the continued evolution in device technology, continued development of state-of-the-art techniques to revascularization of complex lesions, and increased collaboration between a largely multidisciplinary field.

Keywords: Chronic limb-threatening ischemia; Claudication; Endovascular therapy; Peripheral artery disease.

Publication types

  • Review

MeSH terms

  • Chronic Disease
  • Endovascular Procedures* / methods
  • Humans
  • Intermittent Claudication / therapy
  • Ischemia / therapy
  • Limb Salvage / methods
  • Peripheral Arterial Disease* / diagnosis
  • Peripheral Arterial Disease* / surgery
  • Retrospective Studies
  • Risk Factors
  • Treatment Outcome